CMRA (Comera Life Sciences Holdings) Net Margin %: -1,583.82% (As of Sep. 2023)


What is Comera Life Sciences Holdings Net Margin %?

Comera Life Sciences Holdings CMRA Net Margin % is -1,583.82% as of Sep. 2023.

Net margin is calculated as Net Income divided by its Revenue. Comera Life Sciences Holdings's Net Income for the three months ended in Sep. 2023 was $-2.15 Mil. Comera Life Sciences Holdings's Revenue for the three months ended in Sep. 2023 was $0.14 Mil. Therefore, Comera Life Sciences Holdings's net margin for the quarter that ended in Sep. 2023 was -1,583.82%.

The historical rank and industry rank for Comera Life Sciences Holdings's Net Margin % or its related term are showing as below:


CMRA's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Comera Life Sciences Holdings  (OTCPK:CMRA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Comera Life Sciences Holdings Net Margin % Related Terms

Comera Life Sciences Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Net Margin % Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Net Margin %
-479.68 -1,703.75 -2,844.23

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1,309.36 -1,899.36 -631.30 -448.25 -1,583.82

CMRA vs FREQ, BNTC, IMNN: Net Margin % Comparison

For the Biotechnology subindustry, Comera Life Sciences Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Comera Life Sciences Holdings Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Comera Life Sciences Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Comera Life Sciences Holdings's Net Margin % falls into.


Comera Life Sciences Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Comera Life Sciences Holdings's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-18.004/0.633
=-2,844.23 %

Comera Life Sciences Holdings's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-2.154/0.136
=-1,583.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1,583.82% mean?
Comera Life Sciences Holdings (CMRA) has a Net Margin % of -1,583.82% as of Sep. 2023. Net margin is the ratio of total net income to net sales. View historical data on Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Net Margin % too high?
Comera Life Sciences Holdings' current Net Margin % is -1,583.82%.
How does Comera Life Sciences Holdings' Net Margin % compare to FREQ and BNTC?
Comera Life Sciences Holdings' Net Margin % of -1,583.82% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Net Margin % is -1,583.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Net Margin % of -1,583.82%. The current Net Margin % is -1,583.82%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Net Margin % is -1,583.82% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.